Indicators
Indicators
Value
Direction
MACD(12,26,9)
-3.813
Neutral
RSI(14)
59.301
Neutral
STOCH(KDJ)(9,3,3)
57.051
Buy
ATR(14)
10.763
High Vlolatility
CCI(14)
77.638
Neutral
Williams %R
31.806
Buy
TRIX(12,20)
0.290
Sell
StochRSI(14)
76.861
Buy
Thermo Fisher Scientific Inc
TMO492.600USD
+3.110+0.64%
Close 09/05, 16:00（ET）Quotes delayed by 15 min
186.01BMarket Cap
28.25P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Currency: USD Updated：2025-09-05Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
31
analysts
Buy
Current Rating
553.506
Target Price
+13.08%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. It also provides proteomics solutions. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial and others. Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 9.41%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 9.41%.
Undervalued
The company’s latest PE is 28.44, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 351.93M shares, decreasing 1.24% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 33.62M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.04.
Financial Health
Currency: USD Updated：2025-09-05The company's current financial score is 8.10, which is higher than the Healthcare Services & Equipment industry's average of 7.15. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 10.36B, representing a year-over-year increase of 0.18%, while its net profit experienced a year-over-year increase of 13.48%.
Score
Financials
7.74
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
7.93
Operational Efficiency
7.52
Growth Potential
8.83
Shareholder Returns
8.48
Company Valuation
Currency: USD Updated：2025-09-05The company’s current valuation score is 4.80, which is higher than the Healthcare Services & Equipment industry's average of 2.15. Its current P/E ratio is 28.18, which is 26.04% below the recent high of 35.52 and -11.11% above the recent low of 31.31.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 5/280
No Data
Earnings Forecast
Currency: USD Updated：2025-09-05The company’s current earnings forecast score is 8.06, which is higher than the Healthcare Services & Equipment industry's average of 7.66. The average price target for Thermo Fisher Scientific Inc is 551.50, with a high of 767.00 and a low of 490.00.
Score
Support & Resistance
No Data
Analyst Rating
Based on
31
analysts
Buy
Current Rating
553.506
Target Price
+12.36%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
93
Total
4
Median
7
Average
Company name
Ratings
Analysts
Thermo Fisher Scientific Inc
TMO
31
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
32
Danaher Corp
DHR
26
1
2
3
...
19
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated：2025-09-05The company’s current price momentum score is 8.99, which is higher than the Healthcare Services & Equipment industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 511.58 and the support level at 455.47, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
489.378
Buy
MA10
490.397
Buy
MA20
486.386
Buy
MA50
458.525
Buy
MA100
435.669
Buy
MA200
481.643
Buy
Institutional Confidence
Currency: USD Updated：2025-09-05The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Services & Equipment industry's average of 7.19. The latest institutional shareholding proportion is 93.19%, representing a quarter-over-quarter increase of 0.45%. The largest institutional shareholder is The Vanguard, holding a total of 33.62M shares, representing 8.90% of shares outstanding, with 2.93% increase in holdings.
Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
State Street Global Advisors (US)
Capital World Investors
Geode Capital Management, L.L.C.
Morgan Stanley Smith Barney LLC
Norges Bank Investment Management (NBIM)
Capital Research Global Investors
JP Morgan Asset Management
1
2
Risk Assessment
Currency: USD Updated：2025-09-05The company's beta value is 0.75. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.78
VaR
+2.51%
240-Day Maximum Drawdown
+37.08%
240-Day Volatility
+31.66%
Return
Best Daily Return
60 days
+9.14%
120 days
+9.14%
5 years
+9.14%
Worst Daily Return
60 days
-3.75%
120 days
-6.83%
5 years
-6.83%
Sharpe Ratio
60 days
+2.45
120 days
+0.01
5 years
+0.21
Risk Assessment
Maximum Drawdown
240 days
+37.08%
3 years
+37.48%
5 years
+41.51%
Return-to-Drawdown Ratio
240 days
-0.56
3 years
+0.01
5 years
+0.05
Skewness
240 days
+0.77
3 years
+0.46
5 years
+0.35
Volatility
Realised Volatility
240 days
+31.66%
5 years
+28.18%
Standardised True Range
240 days
+2.58%
5 years
+2.53%
Downside Risk-Adjusted Return
120 days
+1.08%
240 days
+1.08%
Maximum Daily Upside Volatility
60 days
+34.58%
Maximum Daily Downside Volatility
60 days
+28.02%
Liquidity
Average Turnover Rate
60 days
+0.69%
120 days
+0.69%
5 years
--
Turnover Deviation
20 days
-3.57%
60 days
+39.63%
120 days
+38.18%
Peer Comparison
Currency: USD Updated：2025-09-05Thermo Fisher Scientific Inc
TMO
7.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
PODD
7.89 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Merit Medical Systems Inc
MMSI
7.81 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tenet Healthcare Corp
THC
7.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
BTSG
7.65 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Stevanato Group SpA
STVN
7.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.
